Glenmark Pharmaceuticals informs about disclosure

21 May 2022 Evaluate
Glenmark Pharmaceuticals has informed that the US FDA has issued Form 483 with five observations after an inspection at the Company’s formulation manufacturing facility based out of Goa, India between May 12, 2022 and May 20, 2022.

The above information is a part of company’s filings submitted to BSE.

Glenmark Pharma Share Price

1690.95 -2.35 (-0.14%)
01-Nov-2024 18:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1858.70
Dr. Reddys Lab 1258.55
Cipla 1559.20
Lupin 2198.25
Zydus Lifesciences 1004.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.